and Cell Therapy
May 19–21, 2021
How will gene and cell therapy change health care? Join CEOs, industry leaders, and Harvard’s top medical faculty to assess the future of medicine and the specific actions needed to realize the promise of emerging research for patients everywhere.
The GCT ecosystem.
Pharma. Provider. Venture Capital. Medical Device. Patient. Payer. Government.
Every link in the health care value chain is represented at the virtual World Medical Innovation Forum. It’s an opportunity to collaborate with colleagues across industry and academia to translate GCT’s promise to the front lines of medicine. Be a part of the conversation.
Follow and Subscribe
A first look at the early-stage work of Harvard-based investigators.
The Forum provides an up-close look at research that will create the next wave of GCT-driven healthcare innovation.
Industry leaders will converge for three days of exclusive meetings.
Each year, Mass General Brigham invites leaders from around the world to join in a dialogue that will shape the future of medicine.
Opportunities to see when technologies will become clinical realities.
The Forum program provides insight into the pace of implementation of GCT-based products in clinical settings.
Attendees learn how academic institutions are implementing new GCT-driven technology.
Mass General Brigham, a leader in academic medicine with hospitals in its network, helps set industry priorities for education and training.
Gene and Cell Therapy: Illustrated
Click to view larger.